NDC 66689-032-01 - Morphine Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66689-032
- Requested NDC
- 66689-032-01
- Package NDCs from labels
- 66689-032-01, 66689-032-50, 66689-032-04, 66689-032-16
- Manufacturer
- VistaPharm, Inc.
- Effective date
- 2018-10-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Morphine Sulfate - VistaPharm, Inc. | VistaPharm, Inc. | 2018-10-02 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66689-032-01 | ML - Milliliter | 66689-032 | 343355fd-a11a-47da-ab1c-6b8d2a5385e0 | 1 | 2012-07-24 |
| 66689-032-04 | ML - Milliliter | 66689-032 | 6547bdb2-9395-4f63-a706-80770cd35a5d | 1 | 2012-07-24 |
| 66689-032-16 | ML - Milliliter | 66689-032 | 86a1b1c8-fd3a-4f7d-b9a5-c75c9f89dd66 | 1 | 2012-07-24 |
| 66689-032-50 | ML - Milliliter | 66689-032 | 7da23e7b-e5d7-4fb8-b2a1-f66131ed17a5 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Kidnex IV | GINKGO BILOBA, ALPHA-KETOGLUTARICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MALICUM ACIDUM, PYRUVIC ACID, SUCCINICUM ACIDUM, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, GERMANIUM SESQUIOXIDE, MERCURIUS VIVUS, NUX VOMICA, KIDNEY (SUIS), LYMPH NODE (SUIS), NAPHTHOCHINONUM, NATRUM OXALACETICUM, PHOSPHORUS, URINARY BLADDER (SUIS), ACONITICUM ACIDUM, CIS- | Energique, Inc. | 23de6b8e-7622-4ba6-89f7-37bd151687e2 | 2026-02-26 | Warnings | XF417D3PSL |
| Leader Extra Strength Effervescent Antacid and Pain Reliever | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Cardinal Health | c5d7bf5f-3e59-52f2-e053-2a95a90a4a00 | 2026-02-25 | Warnings | XF417D3PSL |
| MITIGO | MORPHINE SULFATE | Piramal Critical Care, Inc. | 728f3d83-9a63-0c1f-e053-2a91aa0ac7db | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Mitochondria Pro | ARALIA QUINQUEFOLIA, ARNICA MONTANA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, ASCORBICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CALCAREA CARBONICA, CITRICUM ACIDUM, CUPRUM METALLICUM, CYSTEINUM, FERRUM METALLICUM, IODIUM, LEVOTHYROXINUM, MAGNESIUM GLUCONICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM ACETICUM, NADIDUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SELENIUM METALLICUM, SULPHUR, THIAMINUM HYDROCHLORICUM, UBIDECARENONUM, ZINCUM METALLICUM, | Energique, Inc. | 2f365207-b730-428d-9465-8853e86e79ff | 2026-02-18 | Warnings | XF417D3PSL |
| Morphine Sulfate | MORPHINE SULFATE | Cranbury Pharmaceuticals, LLC | d8598654-94ad-4cfb-81d2-9b68e013a428 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Morphine sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | 07993f6c-146b-4728-a2da-6e93089f78ff | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Morphine Sulfate | MORPHINE SULFATE | American Health Packaging | 66a3f607-7f48-490f-84dd-b74dd1ee39e5 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Morphine Sulfate | MORPHINE SULFATE | Hikma Pharmaceuticals USA Inc. | ca359246-4674-4b32-b8b2-673d32b7112f | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Morphine Sulfate | MORPHINE SULFATE | Hikma Pharmaceuticals USA Inc. | 3c847554-3b4b-4d24-a145-2ef7e9b83699 | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.